KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 0.47.

  • Ginkgo Bioworks Holdings' Equity Ratio fell 1263.72% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 1263.72%. This contributed to the annual value of 0.52 for FY2024, which is 2109.41% down from last year.
  • Ginkgo Bioworks Holdings' Equity Ratio amounted to 0.47 in Q3 2025, which was down 1263.72% from 0.5 recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Equity Ratio registered a high of 0.79 during Q2 2022, and its lowest value of 0.21 during Q2 2021.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Equity Ratio value was 0.62 (recorded in 2024), while the average stood at 0.59.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Equity Ratio surged by 28247.05% in 2022, and later crashed by 2186.47% in 2024.
  • Ginkgo Bioworks Holdings' Equity Ratio (Quarter) stood at 0.76 in 2021, then dropped by 9.65% to 0.68 in 2022, then fell by 3.65% to 0.66 in 2023, then fell by 21.09% to 0.52 in 2024, then dropped by 9.45% to 0.47 in 2025.
  • Its Equity Ratio was 0.47 in Q3 2025, compared to 0.5 in Q2 2025 and 0.5 in Q1 2025.